Compass Therapeutics (CMPX) Assets

Price: $1.85
Market Cap: $255.82M
Avg Volume: 1.51M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.187
52W Range: $0.765-4.08
Website: Compass Therapeutics

Compass Therapeutics Asset Metrics Summary

According to Compass Therapeutics's latest annual financial reports, the company's asset profile is as follows:

Total Assets

Compass Therapeutics's total assets amount to $156.88M. This is divided into:

  • Total Current Assets: $153.88M
  • Total Non-current Assets: $2.99M
  • Net Receivables: $-
  • Inventory: $-
  • Cash and Short-term Investments: $152.46M
  • Property, Plant, and Equipment (Net): $2.67M
  • Long-term Investments: $-
  • Goodwill and Intangible Assets: $-

Asset Ratios and Metrics

To better understand Compass Therapeutics's asset management, we can look at several key ratios:

  • Return on Assets (ROA): -27.09% - this indicates how profitable a company is relative to its total assets.
  • Asset Turnover: 0.00 - this shows how efficiently a company uses its assets to generate sales.
  • Current Ratio: 19.73 - this measures a company's ability to pay short-term obligations with its current assets.
  • Quick Ratio: 19.73 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
  • Cash Ratio: 3.11 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.

These metrics provide insight into Compass Therapeutics's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.

Total Assets

$156.88M

Total Current Assets

$153.88M

Total Non-current Assets

$2.99M

Net Receivables

$-

Inventory

$-

Cash and Short-term Investments

$152.46M

Property, Plant, and Equipment (Net)

$2.67M

Long-term Investments

$-

Goodwill and Intangible Assets

$-

Return on Assets

-27.09%

Asset Turnover

0.00

Current Ratio

19.73

Compass Therapeutics Historical Asset Metrics
Total Assets
Total Current Assets
Total Non-current Assets
$250.00M$250.00M$200.00M$200.00M$150.00M$150.00M$100.00M$100.00M$50.00M$50.00M$0.00$0.00Asset MetricsJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '23
Historical Return on Assets
45.69%45.69%-7.66%-7.66%-61.01%-61.01%-114.36%-114.36%Return on AssetsJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024
Historical Total Assets Growth
200.00%200.00%100.00%100.00%0.00%0.00%-100.00%-100.00%Total Assets GrowthJul '19Jul '1920202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024

Compass Therapeutics Historical Assets

The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2023.

Year Total Assets Total Current Assets Total Non-current Assets Net Receivables Inventory Cash and Short-term Investments Property, Plant, Equipment (Net) Long-term Investments Goodwill and Intangible Assets Return on Assets Asset Turnover Current Ratio Quick Ratio Cash Ratio
2023 $156.88M $153.88M $2.99M $- $- $152.46M $2.67M $- $- -0.27 0.00 19.73 19.73 3.11
2022 $199.65M $194.79M $4.85M $- $- $186.61M $4.53M $- $- -0.18 0.00 12.05 12.05 2.16
2021 $153.76M $147.10M $6.65M $- $- $144.51M $6.33M $- $- -0.54 0.00 13.84 13.84 13.59
2020 $51.91M $50.20M $1.71M $- $- $47.08M $1.13M $263.00K $- -0.57 0.00 4.97 4.97 4.66
2019 $30.38M $26.24M $4.14M $- $- $25.30M $3.75M $263.00K $- -1.14 0.00 2.67 2.67 2.58
2018 $64.62M $58.88M $5.74M $- $- $57.51M $5.37M $262.00K $- -0.59 0.00 6.96 6.96 6.79

Related Metrics

Explore detailed financial metrics and analysis for CMPX.